Financial Markets
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

Company - Overseas
 Search News  Or
China Botanic Pharma's profit narrows to US$5.4 mln in Q4

Feb. 1, 2012 (China Knowledge) - China Botanic Pharmaceutical Inc<CBP>, a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines, has posted US$5.4 million-net profit for the fourth quarter of fiscal year 2011 ended Oct. 31, 2011, compared with US$5.6 million the firm realized in the same quarter of fiscal year 2010.  

Diluted earnings per American Depositary Share were US$0.14 in the fourth quarter of fiscal year 2011, less than US$0.15 in the corresponding period of fiscal year 2010.

In the three-month period ended Oct. 31, 2011, the U.S.-listed company reaped US$18.8 million in operating revenue, reflecting a year-on-year increase of 12.8% from US$16.7 million. Gross profit increased by 18.5% to US$10.8 million with gross margin of 57.1%.

In the fiscal year 2011, the Chinese pharmaceutical firm's net profit grew from US$17.9 million to US$25.9 million, and its diluted earnings per ADS increased to US$0.69.

Operating revenue for the fiscal year 2011 totaled US$72.7 million, up 31.8% year on year from US$55.2 million.

As of Oct. 31, 2011, China Botanic Pharmaceutical had US$15.3 million in cash.

For fiscal year 2012, the company expects its revenues to be in the range of US$91.6 million to US$93.1 million, representing an increase of 26% to 28% from a year earlier.

Add this     
Copyright © "2015"

Send feedback or comments to:

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services


 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved